The pharmaceutical community is excited by retatrutide, a new dual GIP and GLP-1 receptor that’s showing impressive results in early studies . This medication works by imitating natural hormones to regulate appetite and boost feelings of fullness , ultimately resulting in noticeable body check here loss . While currently under evaluation and not